Blue Lagoon President & CEO Rana Vig Adds 1Million Shares To His Personal Position
VANCOUVER, BC / ACCESSWIRE / February 22, 2021 / Blue Lagoon Resources Inc. (the “Company“)…
VANCOUVER, BC / ACCESSWIRE / February 22, 2021 / Blue Lagoon Resources Inc. (the “Company“)…
Kagocel and Sputnik V gain confidence from the medical community MOSCOW, RUSSIA / ACCESSWIRE /…
LINK GLOBAL TECHNOLOGIES BEGINS PHASE ONE OF A NEW BITCOIN ROYALTY MINING PROGRAM WITH 800…
BUCHAREST, ROMANIA / ACCESSWIRE / February 22, 2021 / As things are gearing up, xHumanity moves…
VANCOUVER, BC / ACCESSWIRE / February 22, 2021 / XPhyto Therapeutics Corp. (CSE:XPHY / OTCQB:XPHYF…
VANCOUVER, BC / ACCESSWIRE / February 22, 2021 / Ximen Mining Corp. (TSXV:XIM)(FRA:1XMA)(OTCQB:XXMMF) (the “Company”…
SINGAPORE / ACCESSWIRE / February 22, 2021 / Jadestone Energy Inc. (AIM:JSE) (the “Company” or “Jadestone”), an…
THIS NEWS RELEASE IS NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES FOR DISSEMINATION IN THE…
Frankfurt, Germany, February 22, 2021: Today, the Next Generation Mobile Networks (NGMN) Alliance announces its…
Strong second half in European segment with a segment EBITDA margin of 8.9%, above the…
Channel Partners expect significant growth in 2021, despite pandemic 63% of respondents expect business growth…
Register today for Ensign’s unmissable webinar on Why your Network is the secret to the…
London tech company to invest in expanding next generation ‘AI-powered traffic lights’ globally Company plans…
PRESS RELEASE Algenex and Virbac sign international commercial licensing agreement for CrisBio®-based vaccine in major…
Montrouge, France, February 22, 2021 DBV Technologies Announces Appointment of Michele F. Robertson as Chief…
“For a greener today” is the slogan with which JSC Olainfarm launches the renewed Cold…
Press Release 22 February 2021 Immunicum Announces Encouraging Signs of Survival Benefit in Phase II…
DXS INTERNATIONAL PLC (AQSE: DXSP) Notice of Investor Presentation DXS International plc (“DXS”, the “Company”),…
Saint-Herblain (France), February 22, 2021 – Valneva SE (“Valneva” or “the Company”), a specialty vaccine…
— 1st approval of any checkpoint inhibitor in nasopharyngeal carcinoma in the world — 2nd…